Pfizer (NYSE: PFE) reported its Q3 results earlier this week, with revenues missing but earnings beating the street estimates, and we believe that PFE stock has ample ...

Den vollständigen Artikel lesen

Should You Pick Pfizer Stock At $30? - auf forbes.com